Scientists outline blueprint for next-generation wearable eye health sensors
Dr. Yangzhi Zhu of the Terasaki Institute for Biomedical Innovation (TIBI), with collaborators at UC San Diego and USC, published a Nature Sensors perspective on what it will take to turn tear-based wearable sensors into reliable, long-term health-tracking tools.
Scientists have outlined a roadmap for developing next-generation wearable eye health sensors, highlighting the need to consider tears as a central aspect rather than just individual biomarkers. Researchers at the Terasaki Institute for Biomedical Innovation (TIBI), collaborating with teams at UC San Diego and USC, published a perspective in Nature Sensors discussing the challenges and potential solutions for long-term, reliable monitoring of eye conditions like dry eye disease and glaucoma.
Tear films are dynamic physiological systems constantly influenced by blinking, evaporation, and fluid turnover, making them attractive targets for continuous monitoring. However, current sensors have primarily focused on detecting biomarkers without fully addressing the tear film's shifting nature. The research team proposes tailoring each type of biological signal, such as pH and electrolytes versus larger proteins or inflammatory markers, to the most suitable sensing frequency and device format.
They also emphasize the importance of integrating chemical sensing with contextual data, such as blink patterns and tear flow, to differentiate true biological changes from normal fluctuations. The perspective outlines a framework encompassing four key areas: the biological interface, device performance in real-world conditions, clinical translation, and building user trust.
Complementary formats like smart contact lenses, punctal devices, and periocular patches are suggested, each addressing different monitoring needs. Dr. Yangzhi Zhu, a principal investigator at TIBI, stresses the importance of designing sensors and interpretation methods together to ensure trustworthy readings over time. Dry eye disease is identified as an ideal starting point for this approach, with potential applications extending to glaucoma monitoring and metabolic tracking.
To achieve this vision, researchers must transition from short-term wear tests to longitudinal studies comparing tear-based readings with established clinical measures.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
